About
Christopher Gibson, Ph.D., is a biotech entrepreneur best known as co-founder of Recursion Pharmaceuticals, where he served as CEO from 2013 through 2025 and became Chair of the Board on January 1, 2026. He has a background in bioengineering and managerial studies from Rice University and pursued M.D./Ph.D. training at the University of Utah before leaving medical school to build Recursion. Public filings also connect him to Pacific Biosciences as a director, reinforcing his role in the AI-biotech and genomics ecosystem.
Areas of interest
biotechAIdrug discoverycomputational biologygenomicsprecision medicine